Faron Pharmaceuticals Ltd Is A Clinical Stage Biopharmaceutical Company Based In Turkufinlandthe Company Focuses On Developing Innovative Cancer Treatments That Utilize The Patient S Immune Systemfaron Is Listed On The Aim Market And First Northand It Is Recognized For Its Pioneering Work In Macrophage Targeting Therapies Faron S Mission Is To Expand Access To Immunotherapy By Creating New Therapeutic Approaches And Combination Therapiesits Clinical Pipeline Includes Bexmarilimaba First In Class Anti Clever 1 Antibody In Phase I Ii Trials For Hematological Cancersand Traumakinean Investigational Therapy For Acute Respiratory Distress Syndromeadditionallyhaematokine Is Being Developed As A Vap 1 Inhibitor To Support The Expansion Of Human Hematopoietic Stem Cells The Company Collaborates With Academic Institutions And Pharmaceutical Companies To Enhance Its Clinical Development Programsaiming To Address Significant Unmet Medical Needs In Cancer And Inflammatory Conditionsdrjuho Jalkanen Leads Faronfostering A Culture Of Innovation And Teamwork
